RT
PFE icon

Robert Torray’s Pfizer PFE Stock Holding History

Robert Torray’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7M Buy
859,418
+82,963
+11% +$2.17M 2.79% 16
2026
Q1 		$21.8M Sell
776,455
-27,116
-3% -$722K 3.2% 9
2025
Q4 		$20M Buy
803,571
+50,574
+7% +$1.28M 2.87% 13
2025
Q3 		$19.2M Buy
752,997
+102,107
+16% +$2.52M 2.6% 13
2025
Q2 		$15.8M Buy
650,890
+517,746
+389% +$12.1M 2.29% 16
2025
Q1 		$3.37M Buy
+133,144
New +$3.48M 0.5% 59

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Robert Torray's PFE Position: Q2 2026 in Review

Robert Torray increased its Pfizer (PFE) stake by 11% in Q2 2026, buying an estimated $2.17M and bringing the position to 859,418 shares worth $20.7M. The position accounts for 2.79% of the portfolio, ranked #16.

Robert Torray first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $21.8M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Robert Torray held 859,418 shares of Pfizer worth $20.7M as of Q2 2026.
  • Robert Torray bought 82,963 Pfizer shares in Q2 2026, an estimated $2.17M.
  • Pfizer made up 2.79% of Robert Torray's portfolio in Q2 2026, its #16 holding.
  • Robert Torray first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • Robert Torray's Pfizer position peaked at $21.8M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Torray Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.